Posted on 3月 3, 20213/3/21
Webinar: Drug Pricing and Reporting Regulatory Updates Part 2
Posted on 3月 3, 20213/3/21
Webinar: Drug Pricing and Reporting Regulatory Updates Part 1
Posted on 2月 17, 20212/17/21
The Crush: How Covid-19 Is Impacting Mature Brand Revenue & Long-Term Value
Posted on 2月 15, 20212/15/21
How to Determine Price and Global Launch Sequence in a Post-COVID World
Posted on 1月 29, 20211/29/21
Under the Biden Team & Beyond COVID … What Lies Ahead for Healthcare
Posted on 1月 19, 20211/19/21
Moving Forward in Pharma: Reigniting Revenue for Mature Brands
Posted on 9月 21, 20209/21/20
Navigate the Complexity of Proposed CMS Medicaid Rule
Posted on 9月 2, 20209/2/20
CMS Announces Medicare Coverage for FDA-Designated Breakthrough Devices. What Does This Mean?
Posted on 5月 18, 20205/18/20
ISPOR 2020 PANEL: Evidence Standards for Medical Device Adoption by U.S. Hospitals
Posted on 11月 7, 201911/7/19